Clinical Trials Directory

Trials / Completed

CompletedNCT00699114

Analgesic Effect of Ibuprofen, Paracetamol (Acetaminophen), and Paracetamol (Acetaminophen) Plus Codeine on Acute Pain

Analgesic Effect of Ibuprofen 400, 600 and 800 mg, Paracetamol 500 and 1000 mg, and Paracetamol 1000 mg Plus 60 mg Codeine: Single-dose, Randomized, Placebo-controlled and Double-blind Study on Acute Pain After Third Molar Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
350 (estimated)
Sponsor
Ullevaal University Hospital · Academic / Other
Sex
All
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The purpose of this placebo controlled clinical trial is to evaluate the dose response relationship of ibuprofen in doses from 400 mg to 800 mg and paracetamol (acetaminophen)in doses from 500 mg to 1000 mg compared with paracetamol (acetaminophen)1000 mg plus codeine 60 mg on acute postoperative pain after surgical removal of impacted third molars.

Detailed description

Acetaminophen (paracetamol) and related aspirin-like drugs have traditionally been used for pain control of minor to moderate postoperative pain. Gradually traditional non-steroidal anti-inflammatory drugs (NSAIDs) have become more popular as analgesics due to assumed superior therapeutic effects and aggressive marketing campaigns orchestrated by the pharmaceutical industry. Ibuprofen is a widely used analgesic both in non-prescription and prescription doses. A dose-response relationship for low ibuprofen doses is shown. Evidence of a progressing dose response relationship for moderate (i.e. 400 mg) to higher doses is scarce. A possible analgesic ceiling effect has been suggested for doses above 400 mg, although a correlation between given ibuprofen doses above 400 mg and patient serum levels is shown. However, it may be questioned if the plasma concentration of ibuprofen is an important determinator of analgesic drug efficacy. A higher dose is more likely to influence the duration of analgesic effect rather than the peak analgesic effect. There are few clinical trials investigating the dose-response relationship of increasing ibuprofen doses and paracetamol doses. To our knowledge no published study has investigated the dose-response relationship of ibuprofen and paracetamol in the same trial with a negative (i.e. placebo) and a positive (i.e. best standard analgesic treatment) control group.

Conditions

Interventions

TypeNameDescription
DRUGPlaceboLactose as powder in gelatine capsules, single dose
DRUGIbuprofen 400 mgIbuprofen 400 mg as powder in gelatine capsules, single dose
DRUGIbuprofen 600 mgIbuprofen 600 mg as powder in gelatine capsules, single dose
DRUGIbuprofen 800 mgIbuprofen 800 mg as powder in gelatine capsules, single dose
DRUGParacetamol (acetaminophen) 500 mgParacetamol (acetaminophen) 500 mg as powder in gelatine capsules, single dose
DRUGParacetamol (acetaminophen) 1000 mgParacetamol (acetaminophen) 1000 mg as powder in gelatine capsules, single dose
DRUGParacetamol (acetaminophen) 1000 mg + codeine 60 mgParacetamol (acetaminophen) 1000 mg + codeine 60 mg as powder in gelatine capsules, single dose

Timeline

Start date
2007-06-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-06-17
Last updated
2011-07-06

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT00699114. Inclusion in this directory is not an endorsement.